Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 1—January 2017
Letter

Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia

Soraya E. Morales-López, Claudia M. Parra-Giraldo, Andrés Ceballos-Garzón, Heidys P. Martínez, Gerson J. Rodríguez, Carlos A. Álvarez-Moreno, and José Y. RodríguezComments to Author 
Author affiliations: Universidad Popular del Cesar, Valledupar, Colombia (S.E. Morales-López, H.P. Martínez); Pontificia Universidad Javeriana, Bogotá, Colombia (C.M. Parra-Giraldo, A. Ceballos-Garzón); Centro de Investigaciones Microbiológicas del Cesar (CIMCE), Valledupar, Colombia (G.J. Rodríguez, J.Y. Rodríguez); Clínica Laura Daniela, Valledupar (G.J. Rodríguez, J.Y. Rodríguez); Universidad Nacional de Colombia, Bogotá (C.A. Álvarez-Moreno); Clínica Universitaria Colombia, Colsanitas, Colombia (C.A. Álvarez-Moreno)

Main Article

Table

Identification and antifungal susceptibilities of Candida auris clinical isolates of six hospitals, northern region of Colombia, 2016*

Isolate ID
 Hospital no.
 Specimen
origin
 Biochemical identification (system)
 Pre-AFT
 VITEK cards Etest/AMB
FLC
 MCF
 CAS
 VRC
 AMB
24 h
 48 h
001 1 Blood C. haemulonii (VITEK) None 16 0.12 <0.25 0.25 8 0.75 1
002 1 CSF C. tropicalis (MicroScan Walkaway) CAS 16 0.12 <0.25 <0.12 8 0.75 1
003 1 Blood C. famata (API Candida) FLC 16 <0.06 <0.25 <0.12 8 1 1
004 5 Blood C. haemulonii (Phoenix) FLC 16 0.12 <0.25 0.25 >16 1 1.5
005 2 Blood C. haemulonii (VITEK) FLC >64 0.25 0.5 2 >16 1 1.5
006 4 Blood C. haemulonii (VITEK) None >64 0.12 <0.25 0.5 8 1 1
007 3 Peritoneal fluid C. albicans (MicroScan autoSCAN) FLC 16 0.12 <0.25 0.25 8 1 1.5
008 2 Blood C. haemulonii (VITEK) FLC 16 0.12 <0.25 0.25 8 0.38 0.75
009 1 Blood C. tropicalis (MicroScan Walkaway)/ C. famata (API Candida) FLC, CAS 32 0.12 <0.25 0.25 8 2 3
010 5 Bone C. haemulonii (VITEK) FLC, AFG, CAS 16 0.12 <0.25 0.25 8 0.75 1
011 6 Urine C. haemulonii (Phoenix) None 32 0.12 <0.25 0.25 8 1.5 1.5
012 3 Blood C. albicans (MicroScan AutoSCAN) FLC 32 0.12 <0.25 1 8 1 2
013 3 Blood C. haemulonii (VITEK) None 32 0.12 <0.25 1 8 0.75 2
014 3 Blood C. haemulonii (VITEK) FLC >64 0.12 <0.25 2 8 1.5 1.5
015 2 Blood C. haemulonii (VITEK) None 32 0.12 <0.25 0.25 8 0.75 2
016 2 Blood C. haemulonii (VITEK) FLC >64 0.12 <0.25 2 >16 1 2
017
 4
 Blood
 C. haemulonii (VITEK)
 CAS
 >64
 0.12
 <0.25
 2
 >16
2
 4
MIC (mg/L) range 16 to >64 <0.06 to 0.25 <0.25 to 0.5 <0.12 to 2 8 to >16 0.38 to 2 0.75 to 4
MIC50 32 0.12 <0.25 0.25 8 1 1.5
MIC90 >64 0.12 <0.25 2 >16 2 2

*AFG, anidulafungin; AMB, amphotericin B; CAS, caspofungin; CSF, cerebrospinal fluid; FLC, fluconazole; ID, identification; MCF, micafungin; MIC50, minimal inhibitory concentration for 50% of yeast; MIC90, minimal inhibitory concentration for 90% of yeast; Pre-AFT, use of antifungal therapy before the isolation of C. auris; VRC, voriconazole.

Main Article

Page created: December 16, 2016
Page updated: December 16, 2016
Page reviewed: December 16, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external